当前位置:首页 > 文献互助 > 互助详情

Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial复制

用户dezZ-X6r0Kf0 35分钟前 13 10 已关闭

DOI: 10.1016/s2468-1253(25)00129-3复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2468125325001293复制

其他信息:

出版社: Elsevier BV
作者: Silvio Danese; Jessica R Allegretti; Stefan Schreiber; Laurent Peyrin-Biroulet; Vipul Jairath; Geert D'Haens; Jarosław Kierkuś; Rupert W Leong; Andres J Yarur; Michael S Vincent; Anindita Banerjee; Deepa E Chandra; Elena Peeva; Srividya Neelakantan; Kenneth E Hung; Jacqueline M McBride; Daniela Bojic; Karen Lasch; Courtney Schiffman; Brian G Feagan

互助时间线

2025-12-04 11:43:21 [关闭求助]

楼主用户dezZ-X6r0Kf0关闭了求助

2025-12-04 11:34:31 [发起求助]

最新发布的求助